Hanan Tanash
21 – 30 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
(
- Contribution to journal › Article
- 2018
-
Mark
Lung function and CT lung densitometry in 37-to 39-year-old individuals with alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
- 2017
-
Mark
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years
(
- Contribution to journal › Article
-
Mark
Burn injury during long-term oxygen therapy in Denmark and Sweden : The potential role of smoking
(
- Contribution to journal › Article
-
Mark
Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status
(
- Contribution to journal › Article
-
Mark
Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
(
- Contribution to journal › Article
-
Mark
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
(
- Contribution to journal › Article
-
Mark
Risk of cancer after lung transplantation for COPD
(
- Contribution to journal › Article
- 2016
-
Mark
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
(
- Contribution to journal › Article